Saratov JOURNAL of Medical and Scientific Research

Age and age-dependent predictors for the risk assessment in elderly and senile patients with chronic heart failure

Year: 2020, volume 16 Issue: №1 Pages: 172-176
Heading: Тhematic supplement Article type: Original article
Authors: Malinova L.I., Lipatova Т.Е., Zhuk A.A., Dolotovskaya P.V., Furman N.V., Denisova T.P.
Organization: Saratov State Medical University
Summary:

Objective: to assess the presence and nature of age-dependent changes in the predictors used for risk stratification of patients with chronic heart failure (CHF). Material and Methods. We perform an analysis of predictive models of CHF, including a comparative assessment of predictors and age of patients. At the second stage, age-dependent changes in the most commonly predictors of CHF were characterized. The study included hospitalized patients with CHF (36-94 years, n=2764). Results. We analyzed 275 prognostic models based on results of large studies (n=36062±5814). The mean age of the patients involved was 68.9±7.6 years. The major predictors included the patient's age and/or potentially age-dependent parameters: hemoglobin, creatinine, RDW, LVEF, SBP and NT-proBNP. In the study sample all of these parameters correlated with the age of the patients with the maximum correlation strength of "NT-proBNP — age" (R=0.57; p<0.05) and "hemoglobin level — age" (-0.57; p<0.05). Conclusion. The prevalence of mature and elderly patients in the populations of studies used to develop the majority of risk instruments for heart failure is revealed. The age-dependent nature of the predictors used in the risk of heart failure is established (hemoglobin, creatinine, RDW, LVEF, SBP and NT-proBNP). The simultaneous use of age and age-dependent parameters as predictors when creating risk-assessment tools may be considered as one of the reasons for the unsatisfactory quality of risk stratification in CHF, including elderly and senile patients.

Bibliography:
1. Snipelisky D, Chaudhry SP, Stewart GC. The Many Faces of Heart Failure. Card Electrophysiol Clin 2019; 11 (1): 11-20.

2. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016; 37 (27): 2129-200.
3. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation 2006; 113: 1424-33.
4. Pocock SJ, Ariti CA, McMurray J, et al. Predicting survival in heart failure: a risk score based on 39372 patients from 30 studies. Eur Heart J 2013 May; 34 (19): 1404-13.
5. Agostoni P, Corra U, Cattadori G, et al. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167 (6): 2710-8.
6. Lupon J, de Antonio M, GalanA, et al. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment [published correction appears in Mayo Clin Proc. 2013 May; 88 (5): 532]. Mayo Clin Proc 2013; 88 (3): 234-3.
7. Senni M, Parrella P, De Maria R et al. Predicting Heart Failure Outcome from Cardiac and Comorbid Conditions: the 3C-HF Score. Int J Cardiol 2013; 163:206-11.
8. Xanthopoulos A, Tryposkiadis K, Giamouzis G, et al. Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure. Eur J Heart Fail 2018; 20 (3): 614-6.
9. Nutter AL, Tanawuttiwat T, Silver MA. Evaluation of 6 prognostic models used to calculate mortality rates in elderly heart failure patients with a fatal heart failure admission. Congest Heart Fail 2010; 16 (5): 196-201.
10. Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart Fail 2014; 2 (5): 429-36.
11. Wills AK, Lawlor DA, Matthews FE, et al. Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med 2011; 8 (6): e1000440.
12. Delgado J, Bowman K, Ble A, et al. Blood Pressure Trajectories in the 20 Years before Death. JAMA Intern Med 2018; 178(1): 93-9.
13. Obas V, Vasan RS. The aging heart. Clinical Science 2018; 132(13): 1367-82.
14. Martin JE, Sheaff MT. Renal ageing. J Pathol 2007; 211 (2): 198-205.
15. Halawi R, Moukhadder H, Taher A. Anemia in the elderly: a consequence of aging? Expert Rev Hematol 2017; 10 (4): 327-35.
16. Hoffmann JJ, Nabbe КС, van den Broek NM. Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV). Clin Chem Lab Med 2015; 53 (12): 2015-9.
17. Januzzi JL Jr, Chen-Tournoux AA, Christenson RH, et al. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. J Am Coll Cardiol 2018; 71 (11): 1191-200.
18. Denisova TP, Malinova LI, Prokhorov SA. Aging and longevity. Moscow: BINOM, 2007; 256 p.

AttachmentSize
2020-01-1_172-176.pdf389.36 KB

No votes yet